NFKB1 and severe acute respiratory syndrome: NF-κB activation exacerbates lung inflammation caused by SARS-CoV infection, and inhibition of NF-κB signaling significantly reduces such inflammation and increases the survival rate of SARS-CoV-infected mice [50, 51].